+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

RNA-Seq detects a SAMD12-EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas



RNA-Seq detects a SAMD12-EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas



Molecular Genetics and Genomic Medicine 7(3): E00560



We describe a patient presenting with pachygyria, epilepsy, developmental delay, short stature, failure to thrive, facial dysmorphisms, and multiple osteochondromas. The patient underwent extensive genetic testing and analysis in an attempt to diagnose the cause of his condition. Clinical testing included metaphase karyotyping, array comparative genomic hybridization, direct sequencing and multiplex ligation-dependent probe amplification and trio-based exome sequencing. Subsequently, research-based whole transcriptome sequencing was conducted to determine whether it might shed light on the undiagnosed phenotype. Clinical exome sequencing of patient and parent samples revealed a maternally inherited splice-site variant in the doublecortin (DCX) gene that was classified as likely pathogenic and diagnostic of the patient's neurological phenotype. Clinical array comparative genome hybridization analysis revealed a 16p13.3 deletion that could not be linked to the patient phenotype based on affected genes. Further clinical testing to determine the cause of the patient's multiple osteochondromas was unrevealing despite extensive profiling of the most likely causative genes, EXT1 and EXT2, including mutation screening by direct sequence analysis and multiplex ligation-dependent probe amplification. Whole transcriptome sequencing identified a SAMD12-EXT1 fusion transcript that could have resulted from a chromosomal deletion, leading to the loss of EXT1 function. Re-review of the clinical array comparative genomic hybridization results indicated a possible unreported mosaic deletion affecting the SAMD12 and EXT1 genes that corresponded precisely to the introns predicted to be affected by a fusion-causing deletion. The existence of the mosaic deletion was subsequently confirmed clinically by an increased density copy number array and orthogonal methodologies CONCLUSIONS: While mosaic mutations and deletions of EXT1 and EXT2 have been reported in the context of multiple osteochondromas, to our knowledge, this is the first time that transcriptomics technologies have been used to diagnose a patient via fusion transcript analysis in the congenital disease setting.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066079968

Download citation: RISBibTeXText

PMID: 30632316

DOI: 10.1002/mgg3.560


Related references

Deletion of exon 8 from the EXT1 gene causes multiple osteochondromas (MO) in a family with three affected members. Springerplus 5: 71, 2016

Intronic deletion and duplication proximal of the EXT1 gene: a novel causative mechanism for multiple osteochondromas. Genes Chromosomes and Cancer 52(4): 431-436, 2013

Hereditary multiple exostoses Mutations in EXT1 gene and characterization of EXT1, 2 and 3 polymorphic markers in chondrosarcoma. American Journal of Human Genetics 57(4 Suppl. ): A232, 1995

A Novel EXT1 Mutation Identified in a Family with Multiple Osteochondromas. Genetic Testing and Molecular Biomarkers 23(4): 251-254, 2019

New mutations of EXT1 and EXT2 genes in German patients with Multiple Osteochondromas. Annals of Human Genetics 73(Pt 3): 283-291, 2009

One third of Japanese patients with multiple osteochondromas may have mutations in genes other than EXT1 or EXT2. Genetic Testing 12(4): 557-561, 2008

Analysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas. Molecular Genetics and Genomic Medicine 6(3): 382-392, 2018

Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas. Human Mutation 26(3): 280, 2005

Identification of mutations in EXT1 and EXT2 genes in six Chinese families with multiple osteochondromas. Molecular Medicine Reports 16(4): 5599-5605, 2017

Novel and recurrent mutations in the EXT1 and EXT2 genes in Chinese kindreds with multiple osteochondromas. Journal of Orthopaedic Research 31(9): 1492-1499, 2013

Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families. Bmc Medical Genetics 12: 85, 2011

Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas. Journal of Genetics 94(4): 749-754, 2015

Mutation screening for the EXT1 and EXT2 genes in Chinese patients with multiple osteochondromas. Archives of Medical Research 44(7): 542-548, 2013

Identification of a novel mutation in the EXT1 gene from a patient with multiple osteochondromas by exome sequencing. Molecular Medicine Reports 15(2): 657-664, 2017

Exome sequencing and functional analysis identifies a novel mutation in EXT1 gene that causes multiple osteochondromas. Plos one 8(8): E72316, 2013